A “next generation” immunotherapy treatment that has the potential to cure leukaemia has been given NHS approval. Obe-cel is a type of CAR T-cell therapy developed in the UK and works by genetically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback